| Fungal sensitisation in severe asthma is associated with the identification of Aspergillus fumigatus in sputum J Farrant, H Brice, S Fowler, R Niven Journal of Asthma 53 (7), 732-735, 2016 | 44 | 2016 |
| Copper chelation in patients with hypertrophic cardiomyopathy A Reid, C Miller, JP Farrant, R Polturi, D Clark, S Ray, G Cooper, ... Open Heart 9 (1), e001803, 2022 | 18 | 2022 |
| Use of awake proning to avoid invasive ventilation in a patient with severe COVID-19 pneumonitis P Whittemore, L Macfarlane, A Herbert, J Farrant BMJ Case Reports CP 13 (8), e236586, 2020 | 8 | 2020 |
| Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy J Farrant, S Dodd, C Vaughan, A Reid, M Schmitt, C Garratt, M Akhtar, ... Heart 109 (15), 1175-1182, 2023 | 7 | 2023 |
| P236 relationship between bone mineral density and bone turnover markers in severe asthma patients on systemic corticosteroids HGT Brice, JP Farrant, SJ Fowler, LJ Holmes, J Tang, C Washbourne, ... Thorax 69 (Suppl 2), A180-A181, 2014 | 2 | 2014 |
| S60 Aspergillus Polymerase Chain Reaction Testing in the Severe Asthma Population JP Farrant, H Wardman, L Holmes, L Chishimba, R Niven Thorax 67 (Suppl 2), A31-A31, 2012 | 2 | 2012 |
| S89 The use of Aspergillus Polymerase chain reaction testing to gain a further understanding of severe fungal allergic asthma JP Farrant, L Holmes, R Masania, L Chishimba, R Niven Thorax 68 (Suppl 3), A48-A48, 2013 | 1 | 2013 |
| Identification of heart failure hospitalization from NHS Digital data: comparison with expert adjudication F Soltani, J Bradley, A Bonandi, N Black, JP Farrant, A Pailing, ... ESC Heart Failure 11 (2), 1022-1029, 2024 | | 2024 |
| Considerations for drug trials in hypertrophic cardiomyopathy JP Farrant, M Schmitt, AB Reid, CJ Garratt, WG Newman, A Malhotra, ... ESC Heart Failure, 2024 | | 2024 |
| Development and validation of imaging-free myocardial fibrosis prediction models, association with outcomes, and sample size estimation for phase 3 trials N Black, J Bradley, G Lewis, J Lagan, C Orsborne, F Soltani, JP Farrant, ... medRxiv, 2024.02. 07.24302443, 2024 | | 2024 |
| EPS1. 09 Feasibility of cardiac magnetic resonance imaging in older cystic fibrosis patients K Sapru, C Orsborne, J Farrant, N Black, C Miller, D Clarke, M Westwell, ... Journal of Cystic Fibrosis 22, S39, 2023 | | 2023 |
| Trientine in hypertrophic cardiomyopathy: rationale and design of the TEMPEST trial J Farrant Heart 1175, 109, 2023 | | 2023 |
| Copper Chelation in patients with Hypertrophic Cardiomyopathy: Insights from an open-label pilot study of Trientine in patients with hypertrophic cardiomyopathy AB Reid, CA Miller, JP Farrant, R Potluri, D Clark, S Ray, G Cooper, ... Open Heart, 2021 | | 2021 |
| Quantitative Magnetisation Transfer Imaging using bSSFP to assess diffuse myocardial fibrosis. L Pleva, J Farrant, C Miller, J Naish | | |
| Airways disease: fungus and the bogeyman JP Farrant, L Holmes, R Masania, L Chishimba, R Niven | | |
Christopher A MillerUniversity of Manchester在 manchester.ac.uk 的电子邮件经过验证
